CN V3 Blog - Consultant's Corner - Mini Blog

Article

Mr. Paivanas is the President and Founding Director of Thomas A. Paivanas & Associates (TAP&A) and has over 25 years of experience in the health care field.  The firm specializes in assisting clients in realizing particularly difficult oncology and health care opportunities and challenges.  Areas of interest and expertise include oncology program integration across multi-institutional venues, strategic business planning for stem cell transplantation, academic and community hospital partnering, primary market research for pharmaceutical industry, strategic planning for private and faculty physician's practices, practice mediation, strategic business planning for biotech companies, and comprehensive community cancer program development.

Thomas A. Paivanas, MHSA paivanas@verizon.net

Mr. Paivanas is the President and Founding Director of Thomas A. Paivanas & Associates (TAP&A) and has over 25 years of experience in the health care field.  The firm specializes in assisting clients in realizing particularly difficult oncology and health care opportunities and challenges.  Areas of interest and expertise include oncology program integration across multi-institutional venues, strategic business planning for stem cell transplantation, academic and community hospital partnering, primary market research for pharmaceutical industry, strategic planning for private and faculty physician's practices, practice mediation, strategic business planning for biotech companies, and comprehensive community cancer program development.

Martin Neltner mneltner@earthlink.net

Martin Neltner is the President and Founder of Neltner Billing and Consulting, a full-service medical management with particular expertise in oncology. Mr. Neltner, a nationally recognized practice management and billing specialist, has testified before congressional committees and the AMA regarding financial issues affecting the delivery of cancer care. He is an avid health care blogger and has written numerous white papers as well as articles and abstracts appearing in peer review publications. Mr. Neltner regularly conducts seminars across the country on topics such as coding, documentation, reimbursement, cancer care management and options for negotiating contractual arrangements.

Recent Videos
Brett L. Ecker, MD, discusses the importance of multidisciplinary collaboration in improving patient outcomes in neuroendocrine tumors.
2 experts are featured in this series.
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Related Content
For patients with KRAS-mutated colorectal cancer, onvansertib plus FOLFIRI/bevacizumab was effective in those who had not received prior bevacizumab.

Onvansertib Combo Shows Significant Efficacy in KRAS+ Colorectal Cancer

Tim Cortese
November 26th 2024
Article

For patients with KRAS-mutated colorectal cancer, onvansertib plus FOLFIRI/bevacizumab was effective in those who had not received prior bevacizumab.

Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.

Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer

Tanios S. Bekaii-Saab, MD, FACP
November 25th 2024
Podcast

Tanios S. Bekaii-Saab, MD, provides an overview of current therapy options and ongoing initiatives involving targetable alterations in those with pancreatic cancer.

A computational linguistics model has mitigated disparities in surveillance of the pancreas that primarily affected racial and ethnic minorities.

Bridging Racial and Ethnic Minority Disparities in Pancreatic Cyst Surveillance

Russell C. Langan, MD
November 25th 2024
Article

A computational linguistics model has mitigated disparities in surveillance of the pancreas that primarily affected racial and ethnic minorities.

A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.

Collaboration Fosters Treatment Advancements for Young Lymphoma Populations

Andrew M. Evens, DO, MS
November 18th 2024
Podcast

A leader from the adolescent and young adult lymphoma space discusses how collaboration between adult and pediatric oncologists has transformed the field.

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells

American Society for Transplantation and Cellular Therapy
November 25th 2024
Article

Researchers at SickKids Hospital and McMaster University have developed a novel CAR T-cell therapy targeting ROBO1 for the treatment of recurrent glioblastoma.

Belantamab Mafodotin Combos Accepted for Review by FDA in Multiple Myeloma

Belantamab Mafodotin Combos Accepted for Review by FDA in Multiple Myeloma

Tim Cortese
November 25th 2024
Article

A BLA has been accepted by the FDA for 2 belantamab mafodotin combinations that have shown positive results in patients with multiple myeloma.